Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03434223 · ClinicalTrials.gov registry record

Prospective Follow-up of Elderly Patients Undergoing Instrumented Lumbar Arthrodesis Supplemented by the Implanet Jazz System(TM)

A clinical trial, sponsored by Ohio State University.

Terminated
Registry status
3
Enrollment target

NCT03434223: Clinical Trial study, sponsored by Ohio State University.

NCT03434223 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03434223 was terminated before completion, sponsored by Ohio State University.

TERMINATED
Registry status
3 participants
Enrollment target

Study Summary

Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2016-12-29
Est. Completion 2019-06-06
Ohio State University

552 total trials

Why NCT03434223 stopped before completion

NCT03434223 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03434223 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03434223 about?

NCT03434223 is a clinical study titled "Prospective Follow-up of Elderly Patients Undergoing Instrumented Lumbar Arthrodesis Supplemented by the Implanet Jazz System(TM)". Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.

What is the current status of trial NCT03434223?

This trial is currently terminated. The enrollment target is 3 participants. The study started on 2016-12-29. Estimated completion is 2019-06-06.

Who is sponsoring clinical trial NCT03434223?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03434223, the US trial registry maintained by the National Library of Medicine. NCT03434223 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.